Skip to content
Screener

Sionna Therapeutics SION Q1 2025 earnings

Reported May 12, 2025 · Before market open

EPS-$0.62Miss by $0.17
EPS estimate-$0.45

Next report

Nov 4, 2026 (in 2 months)
EPS estimate-$0.64

Financials

Q1 2025

Income statement

See full
Operating income-$19.7M-49.5%
Net income-$16.5M-39.1%
EPS (diluted)-$0.62+100.0%

Balance sheet

See full
Cash & equivalents$83.7M-0.1%
Total debt$9.5M—
Total equity$351.8M+379%
Total assets$369.7M—

Cash flow

See full
Operating cash flow-$16.3M-23.6%
CapEx$86.0K—
Free cash flow-$16.4M-24.3%

FAQ

When did Sionna Therapeutics report Q1 2025 earnings?
Sionna Therapeutics (SION) reported Q1 2025 earnings on May 12, 2025 before market open.
What were Sionna Therapeutics's Q1 2025 revenue and EPS?
Sionna Therapeutics reported eps of $-0.62 for Q1 2025.
Did Sionna Therapeutics beat estimates in Q1 2025?
EPS missed the consensus estimate of $-0.45 by $0.17.
Where can I find Sionna Therapeutics's Q1 2025 SEC filings?
You can read the 8-K earnings release (0002036042-25-000014) and the 10-Q periodic report (0002036042-25-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.